Key result
This review provides a conceptual framework for the periprocedural management of antithrombotic therapy in hospitalized patients requiring invasive procedures.
Why the study?
How should antithrombotic therapy be managed periprocedurally in hospitalized patients requiring invasive procedures?
How should antithrombotic therapy be managed periprocedurally in hospitalized patients requiring invasive procedures?
This review provides a conceptual framework to guide the periprocedural management of newer and common antithrombotic medications for hospitalized patients undergoing invasive procedures.
May aid periprocedural antithrombotic decisions in hospitalized patients; leaves open prospective validation of framework-guided outcomes.
The management of antithrombotic medications in patients requiring invasive procedures is a common problem in hospital medicine, for which there is limited evidence to guide clinical decision making. Existing guidelines do not address many hospital-based procedures and have not kept pace with the introduction of newer antiplatelet and anticoagulant medications. This article provides a conceptual framework for the periprocedural management of antithrombotic therapy, with a focus on the procedures that hospitalists are most likely to perform and the pharmacology of the common and newer antithrombotic medications.
No takes yet. Share an insight, caveat, or question.
David Feinbloom (2014) conducted a review in Hospitalized patients requiring invasive procedures. Periprocedural management of antithrombotic therapy was evaluated. This review provides a conceptual framework for the periprocedural management of antithrombotic therapy in hospitalized patients requiring invasive procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Dual antiplatelet therapyMore from Journal of Hospital Medicine